Wilmington, Delaware, United States, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global anticoagulants market is projected to flourish at a CAGR of 6.2% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 56.6 billion is anticipated for the market in 2031. As of 2023, the market for anticoagulants is expected to close at US$ 34.7 billion.
The increasing prevalence of cardiovascular diseases, such as heart attacks and strokes, is the major factor expected to boost market growth. Anticoagulants are essential in managing these conditions and reducing the risk of clot-related complications.
Don’t miss out on essential insights – Get your sample copy now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60924
Competitive Landscape
The anticoagulants market is highly fragmented with the presence of a large number of market players. The leading players in the market are investing in new product development, mergers, and acquisitions to gain a competitive edge. Transparency Market Research has profiled the following players in its global anticoagulants market report:
Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Daiichi Sankyo Company, Sanofi, Johnson & Johnson, and Pfizer, Inc.
- Bayer AG has been involved in the development, research, or marketing of NOACs, which are newer and more convenient alternatives to traditional anticoagulant drugs like warfarin. The company have developed innovative formulations or delivery mechanisms to enhance the convenience and patient experience with their anticoagulant therapies.
- In February 2023 – The U.S. Food and Drug Administration (FDA) has approved ALTUVIIIO™, previously referred to as efanesoctocog alfa, a first-in-class, high-sustained factor VIII replacement therapy. ALTUVIIIO is indicated for routine prophylaxis and on-demand treatment to control bleeding episodes, as well as perioperative management (surgery) for adults and children with hemophilia A.
With the growing geriatric population, the risk of developing clotting disorders and related conditions such as atrial fibrillation (AFib) increases, driving the demand for anticoagulant medications.
Anticoagulants are widely used to prevent venous thromboembolism (VTE), which includes conditions like DVT and pulmonary embolism, especially in patients undergoing surgeries or immobile patients.
The demand for anticoagulants rises due to the increased number of patients undergoing major surgeries or hospitalized for various conditions who often require anticoagulation to prevent clot formation during recovery. Increasing awareness about different clotting disorders and advances in diagnostic techniques have led to earlier detection and treatment, boosting the demand for anticoagulants.
Key Takeaways from the Market Study
- As of 2022, the anticoagulants market was valued at US$ 32.6 billion
- By route of administration, the oral segment to enjoy high demand, accumulating a high revenue share during the forecast period
- Based on drug class, the XA inhibitors segment accounts for the highest market share
- Based on indication, the atrial fibrillation & heart attack segment dominated the global market during the forecast period, Atrial fibrillation can cause conditions such as blood clots, stroke, heart failure, overactive thyroid gland or other metabolic imbalance, and other issues, which lead to thromboembolic
Anticoagulants Market: Key Trends and Opportunistic Frontiers
- Increase in the number of knee and hip replacement surgeries raises the risk of developing deep vein thrombosis, boosting the demand for anticoagulants.
- The growing improvements in healthcare infrastructure and access to medical services in developing regions lead to better diagnosis and treatment of clotting disorders, which is driving the demand for anticoagulants during the forecast period.
- Advances in pharmacogenomics enable tailoring anticoagulant therapy based on an individual's genetic profile, improving treatment outcomes and reducing adverse effects.
- The development of novel oral anticoagulants (NOACs), also known as direct oral anticoagulants (DOACs), has provided alternatives to traditional therapies, leading to increased adoption of anticoagulants.
Get Exclusive Discount on Anticoagulants Market at: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=60924
Anticoagulants Market – Regional Analysis
- North America is expected to account for a major share of the anticoagulant market during the forecast period due to the high incidence of orthotic conditions among people over the age of 60 in the region. The increasing prevalence of cardiovascular diseases, atrial fibrillation (AFib), and other conditions that require anticoagulant treatment, are expected to boost the market growth in the region.
- Asia Pacific is projected to account for a significant market share during the forecast period. The increase in cardiovascular diseases and clotting disorders in the region drives the market demand. The improved healthcare infrastructure, and increased rate of diagnosis & treatments boost the market demand in countries like China and Japan in the region in the next few years.
Anticoagulants Market – Key Segments
Drug Class
- Factor XA Inhibitors (NOAC/DOAC)
- Heparins
- Direct Thrombin Inhibitors
- Vitamin K Antagonists
Route of Administration
- Oral
- Injectable
- Indication
- Deep Vein Thrombosis
- Pulmonary Embolism
- Atrial Fibrillation & Heart Attack
- Ischemic Stroke
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
Place an Order Copy of Anticoagulants Market Report at: https://www.transparencymarketresearch.com/checkout.php?rep_id=60924<ype=S
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
